1) 日本婦人科腫瘍学会編 : 子宮体癌治療ガイドライン.pp17─19,金原出版,東京,2006
2) 日本産科婦人科学会婦人科腫瘍委員会報告.日産婦誌61 : 939─963,2009
3) 日本婦人科腫瘍学会編 : 子宮体癌治療ガイドライン.pp109─111,金原出版,東京,2006
4) 上坊敏子,大河原聡,土屋源一,他 : 若年子宮体癌の臨床病理学的検討.日癌治誌24 : 22─28,1989
5) Ota T, Yoshida M, Kimura M, et al : Clinicopathologic study of uterine endometrial carcinoma in young women aged 40 years and younger. Int J Gynecol Cancer 15 : 657─662, 2005
6) Dusca LR, Garrett A, Rueda BR, et al : Endometrial cancer in women 40 years old or younger. Gynecol Oncol 83 : 388─393, 2001
7) Kurabayashi T, Kase H, Suzuki M, et al : Endometrial abnormalities in infertile women. J Reprod Med 48 : 455─459, 2003
8) Fujiwara H, Ogawa S, Motoyama M, et al : Frequency and characteristics of endometrial carcinoma and atypical hyperplasia detected on routine infertility investigation in young women : a report of six cases. Hum Reprod 24 : 1045─1050, 2009
9) Navarria I, Usel M, Rapiti E, et al : Young patients with endometrial cancer : How many could be eligible for fertility-sparing treatment? Gynecol Oncol, in print(Epub ahead of print)
10) Walsh C, Holschneider C, Hoang Y, et al : Coexisting ovarian malignancy in young women with endometrial cancer. Obstet Gynecol 106 : 693─699, 2005
11) Ushijima K, Yahata H, Yoshikawa H, et al : Multicenter phase II study of fertile-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25 : 2798─2803, 2007
12) Yamazawa K, Hirai M, Fujito A, et al : Fertility- preserving treatment with progestin, and pathological criteria to predict responses, in young women with endometrial cancer. Hum Reprod 22 : 1953─1958, 2007
13) Soliman PT, Solmovitz BM, Broaddus RR, et al : Synchronous primary cancers of the endometrium and ovary : a single institution review of 84 cases. Gynecol Oncol 94 : 456─462, 2004
14) Kelley RM, Baker WH : Effects of 17 alpha hydroxyprogesterone caproate on metastatic endometrial cancer. Natl Cancer Inst Monogr 9 : 235, 1960
15) Kennedy BJ : Progesterones in the treatment of carcinoma of the endometrium. Surg Gynecol Obstet 127 : 103─114, 1968
16) Wait RB : Megestrol acetate in the management of advanced endometrial carcinoma. Obstet Gynecol 41 : 129─136, 1973
17) 栗原操寿,岡田弘二,秋谷 清,他 : 子宮内膜癌に対するMedroxyprogesterone acetate(MPA)の治療効果に関する検討.産婦の実際34 : 517─536,1985
18) Bokhman JV, Chepick OF, Volkova AT, et al : Can primary endometrial carcinoma stage I be cured without surgery and radiation therapy? Gynecol Oncol 20 : 139─155, 1985
19) Kim YB, Holschneider CH, Ghosh K, et al : Progestin alone as primary treatment of endometrial carcinoma in premenopausal women. Cancer 79 : 320─327, 1997
20) Randall TC, Kurman RJ : Progestin treatment of atypical hyperplasia and well differentiated carcinoma of the endometrium in women under age 40. Obstet Gynecol 90 : 434─440, 1997
21) Imai M, Jobo T, Sato R, et al : Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus─Usefulness and limitations. Eur J Gynaec Oncol 22 : 217─220, 2001
22) Kaku T, Yoshikawa H, Tsuda H, et al : Conservative therapy for adenocarcinoma and atypical hyperplasia of the endometrium in young women : central pathologic review and treatment outcome. Cancer Lett 167 : 39─48, 2001
23) Gotlieb WH, Beiner ME, Shalmon B, et al : Outcome of fertility-sparing treatment with progestins in young patients with endometrial cancer. Obstet Gynecol 102 : 718─725, 2003
24) Minaguchi T, Nakagawa S, Takazawa Y, et al : Combined phosphor-Akt and PTEN expressions associated with post-treatment hysterectomy after conservative progestin therapy in complex atypical hyperplasia and stage Ia, G1 adenocarcinoma of the endometrium. Cancer Lett 248 : 112─122, 2007
25) Eftekhar Z, Izadi-Mood N, Yarandi F, et al : Efficacy of Megestrol acetate(Megace)in the treatment of patients with early endometrial adenocarcinoma : our experience with 21 patients. Int J Gynecol Cancer 19 : 249─252, 2009
26) 田上慶子,丹羽憲司,伊藤直樹,他 : 若年性子宮内膜癌温存療法後の長期的転機.日産婦誌55 : 407, 2003
27) Thigpen JT, Brady MF, Alvarez RD, et al : Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma : A dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17 : 1736─1744, 1999
28) Wheeler DT, Bristow RE, Kurman RJ : Histologic alteration in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 31 : 988─998, 2007
29) 岡田弘二,山本 宝 : 進行体癌の治療.癌と化学療法17 : 1848─1855,1990
30) Yahata T, Fujita K, Aoki Y, et al : Long-term conservative therapy for endometrial adenocarcinoma in young women. Hum Reprod 21 : 1070─1075, 2006
31) Ferrandina G, Zannoni GF, Gallotta V, et al : Progression of conservatively treated endometrial carcinoma after full term pregnancy : A case report. Gynecol Oncol 99 : 215─217, 2005